One-year outcomes of resveratrol supplement with aflibercept versus aflibercept monotherapy in wet age-related macular degeneration

One-year outcomes of resveratrol supplement with aflibercept versus aflibercept monotherapy in wet age-related macular degeneration

AIM: To determine the one-year outcomes of resveratrol oral supplement in patients suffering from wet age-related macular degeneration (AMD). METHODS: Fifty naïve and previously untreated patients suffering from wet AMD, were randomly assigned in two subgroups of 25 patients each. All the participan...

Full description

Bibliographic Details
Main Authors: Ioannis Datseris, Nikolaos Bouratzis, Charalambos Kotronis, Iordanis Datseris, Malvina-Efthimia Tzanidaki, Alexandros Rouvas, Nikolaos Gouliopoulos
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2023-09-01
Series:International Journal of Ophthalmology
Subjects:
wet age-related macular degeneration
resveratrol
aflibercept
hospital anxiety and depression scale
contrast sensitivity
Online Access:http://ies.ijo.cn/en_publish/2023/9/20230917.pdf

Internet

http://ies.ijo.cn/en_publish/2023/9/20230917.pdf

Similar Items